RHYTHM PHARMACEUTICALS, INC.'s CEO and President just disposed of 563 shares https://t.co/P2G6TX92SB $RYTM
$RYTM Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare… https://t.co/VOSjof4IgU
Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Geneti… https://t.co/YbxtM4llfb
Zacks: Brokerages Anticipate Rhythm Pharmaceuticals Inc $RYTM to Post -$0.56 EPS https://t.co/iTJeILdBw9
24,890 Shares in Rhythm Pharmaceuticals Inc (RYTM) Purchased by Tekla Capital Management LLC https://t.co/KiLJHq8OZW
Rhythm Pharmaceuticals Inc $RYTM Given Consensus Rating of “Buy” by Brokerages https://t.co/9JRRclq888
Rhythm Pharmaceuticals Inc $RYTM Given Consensus Rating of “Buy” by Brokerages https://t.co/BLs17UxoW9 #stocks
Rhythm Pharmaceuticals Inc $RYTM Expected to Post Earnings of -$0.56 Per Share https://t.co/UiDCKXVOzG
Zacks: Brokerages Expect Rhythm Pharmaceuticals Inc $RYTM to Announce -$0.56 Earnings Per Share https://t.co/BSWzbUMkWA
Rhythm Pharmaceuticals Inc $RYTM Shorts Decreased by 12.38% After Short Covering - https://t.co/72wgHhf2Sn
Rhythm Pharmaceuticals Inc $RYTM Reports Decline in Sellers; Strong Momentum for Longs https://t.co/I2AZJy3d4j
Could Rhythm Pharmaceuticals Inc $RYTM Go Down After Its Newest Short Interest Report? - https://t.co/mD2IXYCkTt
Will Rhythm Pharmaceuticals Inc $RYTM Run Out of Steam Soon? Short Interest Is Down https://t.co/BR4YNoQb4m
-$0.56 Earnings Per Share Expected for Rhythm Pharmaceuticals Inc $RYTM This Quarter https://t.co/MGHRhVpqjK
200 DMA Support today: $RYTM $QSR ... https://t.co/LjP7KUcNnp